$1.04 Billion is the total value of PURA VIDA INVESTMENTS, LLC's 121 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 203.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Buy | ISHARES TRput | $88,342,000 | +176.8% | 617,000 | +121.3% | 8.50% | +124.3% |
| IHI | New | ISHARES TRput | $49,777,000 | – | 188,000 | +100.0% | 4.79% | – |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $31,132,000 | +42.1% | 1,060,731 | +16.4% | 2.99% | +15.1% |
| ATRC | Buy | ATRICURE INC | $30,803,000 | +135.7% | 685,273 | +76.2% | 2.96% | +90.9% |
| SYK | New | STRYKER CORPORATIONput | $27,569,000 | – | 153,000 | +100.0% | 2.65% | – |
| ICUI | Buy | ICU MED INC | $24,744,000 | -3.3% | 134,251 | +5.9% | 2.38% | -21.7% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INCcall | $22,897,000 | +27.5% | 204,000 | +2.0% | 2.20% | +3.3% |
| SRPT | Buy | SAREPTA THERAPEUTICS INCput | $21,229,000 | +67.7% | 132,400 | +2.3% | 2.04% | +35.9% |
| BMY | New | BRISTOL-MYERS SQUIBB COcall | $17,993,000 | – | 306,000 | +100.0% | 1.73% | – |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $17,652,000 | +39.1% | 944,958 | +7.6% | 1.70% | +12.7% |
| UNH | New | UNITEDHEALTH GROUP INCput | $16,812,000 | – | 57,000 | +100.0% | 1.62% | – |
| VEEV | New | VEEVA SYS INCput | $14,300,000 | – | 61,000 | +100.0% | 1.38% | – |
| XENT | Buy | INTERSECT ENT INC | $13,870,000 | +71.7% | 1,024,374 | +50.2% | 1.33% | +39.1% |
| LHCG | New | LHC GROUP INC | $11,568,000 | – | 66,359 | +100.0% | 1.11% | – |
| OCX | Buy | ONCOCYTE CORP | $11,429,000 | -16.4% | 5,983,724 | +7.3% | 1.10% | -32.3% |
| PROF | Buy | PROFOUND MED CORP | $9,716,000 | +83.9% | 573,556 | +5.8% | 0.93% | +49.0% |
| NVRO | New | NEVRO CORPput | $8,482,000 | – | 71,000 | +100.0% | 0.82% | – |
| ABT | New | ABBOTT LABSput | $8,412,000 | – | 92,000 | +100.0% | 0.81% | – |
| SRPT | Buy | SAREPTA THERAPEUTICS INCcall | $8,177,000 | +67.2% | 51,000 | +2.0% | 0.79% | +35.3% |
| CNMD | New | CONMED CORP | $7,912,000 | – | 109,900 | +100.0% | 0.76% | – |
| KIDS | Buy | ORTHOPEDIATRICS CORP | $7,532,000 | +27.9% | 172,113 | +15.9% | 0.72% | +3.6% |
| LIVN | New | LIVANOVA PLC | $7,290,000 | – | 151,473 | +100.0% | 0.70% | – |
| IMVT | New | IMMUNOVANT INC | $6,594,000 | – | 270,806 | +100.0% | 0.63% | – |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $6,443,000 | +58.0% | 183,500 | +46.8% | 0.62% | +28.1% |
| Buy | DERMTECH INC | $6,233,000 | +79.4% | 471,143 | +52.5% | 0.60% | +45.0% | |
| NVTA | New | INVITAE CORPcall | $6,209,000 | – | 205,000 | +100.0% | 0.60% | – |
| MDT | New | MEDTRONIC PLCput | $5,823,000 | – | 63,500 | +100.0% | 0.56% | – |
| OSUR | Buy | ORASURE TECHNOLOGIES INC | $5,648,000 | +288.7% | 485,600 | +259.6% | 0.54% | +213.9% |
| MRK | New | MERCK & CO. INC | $5,345,000 | – | 69,119 | +100.0% | 0.51% | – |
| INCY | New | INCYTE CORPcall | $5,302,000 | – | 51,000 | +100.0% | 0.51% | – |
| IMMU | New | IMMUNOMEDICS INC | $5,155,000 | – | 145,445 | +100.0% | 0.50% | – |
| GH | Buy | GUARDANT HEALTH INC | $5,103,000 | +34.6% | 62,900 | +15.5% | 0.49% | +9.1% |
| SILK | New | SILK RD MED INC | $4,981,000 | – | 118,900 | +100.0% | 0.48% | – |
| COO | New | COOPER COS INCput | $4,964,000 | – | 17,500 | +100.0% | 0.48% | – |
| MSON | Buy | MISONIX INC | $4,934,000 | +63.7% | 363,586 | +13.6% | 0.48% | +32.7% |
| LIVN | New | LIVANOVA PLCcall | $4,909,000 | – | 102,000 | +100.0% | 0.47% | – |
| ABM | New | ABM INDS INC | $4,763,000 | – | 131,200 | +100.0% | 0.46% | – |
| EW | New | EDWARDS LIFESCIENCES CORPput | $4,630,000 | – | 67,000 | +100.0% | 0.44% | – |
| APYX | Buy | APYX MEDICAL CORPORATION | $4,579,000 | +81.6% | 825,117 | +17.5% | 0.44% | +47.2% |
| AVDL | Buy | AVADEL PHARMACEUTICALS PLCsponsored adr | $4,547,000 | +15.3% | 562,800 | +13.3% | 0.44% | -6.6% |
| NVTA | New | INVITAE CORP | $4,268,000 | – | 140,900 | +100.0% | 0.41% | – |
| KRMD | New | REPRO MED SYS INC | $3,861,000 | – | 429,916 | +100.0% | 0.37% | – |
| IMMU | New | IMMUNOMEDICS INCcall | $3,615,000 | – | 102,000 | +100.0% | 0.35% | – |
| MASI | New | MASIMO CORPput | $3,420,000 | – | 15,000 | +100.0% | 0.33% | – |
| FLDM | New | FLUIDIGM CORP DEL | $3,386,000 | – | 844,300 | +100.0% | 0.33% | – |
| ITMR | Buy | ITAMAR MED LTDsponsored ads | $3,302,000 | +83.2% | 177,547 | +16.1% | 0.32% | +48.6% |
| NVCR | Buy | NOVOCURE LTDcall | $3,285,000 | -10.3% | 55,400 | +1.8% | 0.32% | -27.4% |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $3,251,000 | – | 250,100 | +100.0% | 0.31% | – |
| TRS | New | TRIMAS CORP | $3,185,000 | – | 133,000 | +100.0% | 0.31% | – |
| MRSN | New | MERSANA THERAPEUTICS INC | $2,993,000 | – | 127,900 | +100.0% | 0.29% | – |
| NSTG | New | NANOSTRING TECHNOLOGIES INCcall | $2,994,000 | – | 102,000 | +100.0% | 0.29% | – |
| MYOK | New | MYOKARDIA INC | $2,783,000 | – | 28,800 | +100.0% | 0.27% | – |
| NARI | New | INARI MED INC | $2,767,000 | – | 57,125 | +100.0% | 0.27% | – |
| ARDX | Buy | ARDELYX INC | $2,744,000 | +49.1% | 396,541 | +22.5% | 0.26% | +21.1% |
| GTH | New | GENETRON HLDGS LTDads | $2,617,000 | – | 216,800 | +100.0% | 0.25% | – |
| LYRA | New | LYRA THERAPEUTICS INC | $2,245,000 | – | 198,011 | +100.0% | 0.22% | – |
| NUVA | New | NUVASIVE INCput | $2,087,000 | – | 37,500 | +100.0% | 0.20% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $2,080,000 | – | 436,500 | +100.0% | 0.20% | – |
| IRTC | New | IRHYTHM TECHNOLOGIES INCput | $2,028,000 | – | 17,500 | +100.0% | 0.20% | – |
| BMYRT | Buy | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $1,653,000 | +118.9% | 461,622 | +132.3% | 0.16% | +76.7% |
| CHAQU | New | CHARDAN HEALTHCR ACQSTN 2 COunit 99/99/9999 | $1,617,000 | – | 153,960 | +100.0% | 0.16% | – |
| FLXN | New | FLEXION THERAPEUTICS INC | $1,615,000 | – | 122,800 | +100.0% | 0.16% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $1,543,000 | – | 102,300 | +100.0% | 0.15% | – |
| CRBP | Buy | CORBUS PHARMACEUTICALS HLDGScall | $1,459,000 | +63.9% | 173,900 | +2.4% | 0.14% | +32.1% |
| XENT | New | INTERSECT ENT INCcall | $1,381,000 | – | 102,000 | +100.0% | 0.13% | – |
| LQDA | New | LIQUIDIA TECHNOLOGIES INC | $1,263,000 | – | 150,000 | +100.0% | 0.12% | – |
| CNST | New | CONSTELLATION PHARMCETICLS I | $1,229,000 | – | 40,900 | +100.0% | 0.12% | – |
| MCRB | New | SERES THERAPEUTICS INCcall | $1,219,000 | – | 256,000 | +100.0% | 0.12% | – |
| QURE | New | UNIQURE NV | $1,154,000 | – | 25,600 | +100.0% | 0.11% | – |
| PSNL | New | PERSONALIS INC | $1,131,000 | – | 87,211 | +100.0% | 0.11% | – |
| BTAI | New | BIOXCEL THERAPEUTICS INC | $1,087,000 | – | 20,500 | +100.0% | 0.10% | – |
| INO | New | INOVIO PHARMACEUTICALS INCcall | $1,078,000 | – | 40,000 | +100.0% | 0.10% | – |
| RVNC | New | REVANCE THERAPEUTICS INC | $999,000 | – | 40,900 | +100.0% | 0.10% | – |
| LEGN | New | LEGEND BIOTECH CORPsponsored ads | $872,000 | – | 20,500 | +100.0% | 0.08% | – |
| VSTM | New | VERASTEM INC | $862,000 | – | 501,384 | +100.0% | 0.08% | – |
| SVRA | Buy | SAVARA INC | $868,000 | +20.1% | 348,768 | +2.3% | 0.08% | -3.5% |
| ZYNE | New | ZYNERBA PHARMACEUTICALS INCcall | $806,000 | – | 239,300 | +100.0% | 0.08% | – |
| STSA | New | SATSUMA PHARMACEUTICALS INC | $802,000 | – | 27,872 | +100.0% | 0.08% | – |
| Buy | TRILLIUM THERAPEUTICS INC | $799,000 | +104.9% | 98,787 | +2.4% | 0.08% | +67.4% | |
| ZYME | New | ZYMEWORKS INC | $739,000 | – | 20,500 | +100.0% | 0.07% | – |
| EOLS | Buy | EVOLUS INCcall | $694,000 | +30.7% | 131,000 | +2.3% | 0.07% | +6.3% |
| New | GOSSAMER BIO INCnote 5.000% 6/0 | $506,000 | – | 5,000 | +100.0% | 0.05% | – | |
| EOLS | New | EVOLUS INCput | $434,000 | – | 81,900 | +100.0% | 0.04% | – |
| Buy | CATABASIS PHARMACEUTICALS IN | $119,000 | +58.7% | 18,510 | +2.2% | 0.01% | +22.2% | |
| FPRX | New | FIVE PRIME THERAPEUTICS INC | $68,000 | – | 11,100 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-02-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ICU MED INC | 26 | Q2 2023 | 4.2% |
| NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
| VIEWRAY INC | 25 | Q2 2023 | 3.2% |
| LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
| ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
| INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
| INVACARE CORP | 22 | Q3 2021 | 2.8% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
| INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
| ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
| ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
| Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
| Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
| Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
| MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
| INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
| MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
| TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2024-02-13 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.